MAP2K1 and melanoma: Zhou and colleagues found that propranolol can induce melanoma cell apoptosis and inhibit the proliferation in vitro and in vivo by inhibiting the phosphorylation of AKT, BRAF, MEK1/2, and ERK1/2 (8).